pharmaphorum
JUNE 12, 2025
Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
ALiEM - Pharm Pearls
OCTOBER 30, 2024
Last Words Substance use disorders (SUD) are similar to other chronic relapsing medical conditions such as diabetes mellitus, congestive heart failure/cardiomyopathy, chronic obstructive pulmonary disorder, and cancer. 2017 Jun;32:660-6. Journal of general internal medicine. PMID 28194688 D’Onofrio G, O’Connor PG, Pantalon MV, et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 24, 2025
Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
pharmaphorum
JUNE 20, 2025
Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)
Pharmacy Times
JUNE 27, 2025
Acalabrutinib had previously received approval in 2017 as a single agent for this same indication. The recent application was granted both priority review and orphan drug designation.
Pharmacy Times
JULY 12, 2025
One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period. 1 Meredith also cited promising outcomes from states like Oregon.
Pharmacy Times
JULY 19, 2025
Am J Prev Med 2017; 53:S172-S181. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Lancet 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. doi:10.1016/j.amepre.2017.07.014
Expert insights. Personalized for you.
Let's personalize your content